ArticleCellular oncology (Dordrecht, Netherlands)2025

Organoid-based drug screening identifies homoharringtonine as a therapeutic agent for anaplastic thyroid cancer via TFEB-mediated lysosomal dysfunction.

Xinyue Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.